The role of stem cell transplantation in the treatment of chronic lymphocytic leukemia
Dreger, P.; Schmitz, N.
Leukemia 11(Suppl): S42-S45
1997
ISSN/ISBN: 0887-6924 PMID: 9178838 Document Number: 471667
Stem cell transplantation (SCT) is increasingly being used for treatment of chronic lymphocytic leukemia (CLL). The present article summarizes available clinical results and discusses important aspects of SCT in patients with CLL including the preferable type of SCT (allogeneic vs autologous), timing of SCT, high-dose regimens, purging, and molecular monitoring of residual disease.
Document emailed within 1 workday
Related Documents
Patriarca, F.; Gaidano, G.; Capello, D.; Zaja, F.; Fanin, R.; Baccarani, M. 2000: Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation Haematologica 85(9): 982-985McClanahan, F.; Gribben, J. 2015: New insights into hematopoietic stem cell transplantation for chronic lymphocytic leukemia: a 2015 perspective Clinical Advances in Hematology and Oncology: H&o 13(9): 586-594
Bastion, Y.; Felman, P.; Dumontet, C.; Espinouse, D.; Coiffier, B. 1992: Intensive radio-chemotherapy with peripheral blood stem cell transplantation in young patients with chronic lymphocytic leukemia Bone Marrow Transplantation 10(5): 467-468
Reiffers, J.; Goldman, J.; Meloni, G.; Cahn, J.Y.; Gratwohl, A. 1994: Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplantation 14(3): 407-410
Yano, S. 2011: The role of allogenic hematopoietic stem cell transplantation for chronic myeloid leukemia in imatinib era Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(5): 759-764
Piro, L.D. 1993: 2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphoma Seminars in Hematology 30(4 Suppl 6: 28-30
Basak, G.; Torosian, T.; Snarski, E.; Niesiobedzka, J.; Majewski, M.; Gronkowska, A.; Urbanowska, E.; Jedrzejczak, W. 2010: Hematopoietic stem cell transplantation for T315I-mutated chronic myelogenous leukemia Annals of Transplantation 15(2): 68-70
Esposito, S.; Taylor, L.A. 1972: The role of deoxyribonuclease in the treatment of chronic lymphocytic leukemia Haematologica 57(12): 803-814
Ruiz-Argüelles, G.J.; Gómez-Almaguer, D.; López-Martínez, B.; Cantú-Rodríguez, O.G.; Jaime-Pérez, Jé.C.; González-Llano, O. 2002: Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia Haematologica 87(8): 894-896
Bee, P.C.; Gan, G.G.; Sangkar, V.J.; Haris, A.R. 2008: Nephrotic syndrome in a patient with relapsed of chronic myeloid leukemia after peripheral blood stem cell transplantation Medical Journal of Malaysia 63(1): 71-72
Ziegler-Heitbrock, H.W.; Munker, R.; Dörken, B.; Gaedicke, G.; Thiel, E. 1986: Induction of features characteristic of hairy cell leukemia in chronic lymphocytic leukemia and prolymphocytic leukemia cells Cancer Research 46(4 Pt 2): 2172-2178
Gómez, M.; Urbano-Ispizua, A.; Cervantes, F.; Fernández-Avilés, F.; Rovira, M.; Carreras, E. 2002: Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation Haematologica 87(9): 1003-1005
Weisser, M.; Tischer, J.; Schnittger, S.; Schoch, C.; Ledderose, G.; Kolb, H.Jochem. 2006: A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation Haematologica 91(5): 663-666
Ghavamzadeh, A.; Iravani, M.; Jabehdar-Maralani, P.; Hajrasouliha, A.; Tavakoli, S. 2003: Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran Haematologica 88(4): Elt13
de Witte, T.; Brand, R.; van Biezen, A.; Delforge, M.; Biersack, H.; Or, R.; Meloni, G.; Bandini, B.; Sierra, J.; Kroger, N.; Gratwohl, A.; Niederwieser, D. 2006: The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes Haematologica 91(6): 750-756
Kantarjian, H.M.; Talpaz, M.; Andersson, B.; Khouri, I.; Giralt, S.; Rios, M.B.; Champlin, R.; Hester, J.; Deisseroth, A.B. 1994: High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia Bone Marrow Transplantation 14(1): 57-61
Rosman, I.S.; Nunley, K.S.; Lu, D. 2011: Leukemia cutis in B-cell chronic lymphocytic leukemia presenting as an episodic papulovesicular eruption Dermatology Online Journal 17(9): 7
Bandini, G.; Michallet, M.; Rosti, G.; Tura, S. 1991: Bone marrow transplantation for chronic lymphocytic leukemia Bone Marrow Transplantation 7(4): 251-253
Zikos, P.; Van Lint, M.T.; Lamparelli, T.; Gualandi, F.; Occhini, D.; Bregante, S.; Berisso, G.; Mordini, N.; Incagliato, M.; Fugazza, G.; Sessarego, M.; Bacigalupo, A. 1998: Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse Haematologica 83(10): 896-903
Boussiotis, V.A.; Freedman, A.S.; Nadler, L.M. 1999: Bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia Seminars in Hematology 36(2): 209-216